Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 5/2017

13.04.2017 | Images in Metabolic Medicine

Unique presentation of cutis laxa with Leigh-like syndrome due to ECHS1 deficiency

verfasst von: S. Balasubramaniam, L. G. Riley, D. Bratkovic, D. Ketteridge, N. Manton, M. J. Cowley, V. Gayevskiy, T. Roscioli, M. Mohamed, T. Gardeitchik, E. Morava, J. Christodoulou

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Clinical finding of cutis laxa, characterized by wrinkled, redundant, sagging, nonelastic skin, is of growing significance due to its occurrence in several different inborn errors of metabolism (IEM). Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)–congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade. Here, we further expand the list of inborn errors of metabolism associated with cutis laxa by describing the clinical presentation of a 17-month-old girl with Leigh-like syndrome due to enoyl coenzyme A hydratase, short chain, 1, mitochondria (ECHS1) deficiency, a mitochondrial matrix enzyme that catalyzes the second step of the beta-oxidation spiral of fatty acids and plays an important role in amino acid catabolism, particularly valine.
Literatur
Zurück zum Zitat Ferdinandusse S, Friederich MW, Burlina A et al (2015) Clinical and biochemical characterization of four patients with mutations in ECHS1. Orphanet Journal of Rare Diseases 10:79 Ferdinandusse S, Friederich MW, Burlina A et al (2015) Clinical and biochemical characterization of four patients with mutations in ECHS1. Orphanet Journal of Rare Diseases 10:79
Zurück zum Zitat Mohamed M, Kouwenberg D, Gardeitchik T et al (2011) Metabolic cutis laxa syndromes. J Inherit Metab Dis 34:907–916 Mohamed M, Kouwenberg D, Gardeitchik T et al (2011) Metabolic cutis laxa syndromes. J Inherit Metab Dis 34:907–916
Zurück zum Zitat Tetreault M, Fahiminiya S, Antonicka H et al (2015) Whole‑exome sequencing identifies novel ECHS1 mutations in Leigh syndrome. Hum Genet 134:981–991 Tetreault M, Fahiminiya S, Antonicka H et al (2015) Whole‑exome sequencing identifies novel ECHS1 mutations in Leigh syndrome. Hum Genet 134:981–991
Metadaten
Titel
Unique presentation of cutis laxa with Leigh-like syndrome due to ECHS1 deficiency
verfasst von
S. Balasubramaniam
L. G. Riley
D. Bratkovic
D. Ketteridge
N. Manton
M. J. Cowley
V. Gayevskiy
T. Roscioli
M. Mohamed
T. Gardeitchik
E. Morava
J. Christodoulou
Publikationsdatum
13.04.2017
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 5/2017
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-017-0036-4

Weitere Artikel der Ausgabe 5/2017

Journal of Inherited Metabolic Disease 5/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.